Lineage Cell Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$128.80 | $130.51 | 11.02% | 11 | $327.32B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.29 | $118.92 | 19.01% | 7 | $183.88B |
| PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
| SAN | Sanofi | Outperform |
16
|
93.08€ | 102.80€ | 17.10% | 9 | 116.22€B |
| MDT | Medtronic | Outperform |
11
|
$80.89 | $92.47 | 18.06% | 9 | $106.54B |
| GSK | GSK | Outperform |
12
|
£17.05 | £17.30 | 14.37% | 12 | £68.36B |
| BAX | Baxter International Inc | Outperform |
17
|
$40.34 | $44.86 | 11.55% | 5 | $20.56B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.91B |
| MDXG | MiMedx Group | Buy |
6
|
$7.31 | $11.85 | 64.16% | 1 | $909.11M |
| OFIX | Orthofix Medical | Hold |
10
|
$13.03 | $18.00 | 15.12% | 2 | $487.87M |
| AXGN | AxoGen | Buy |
6
|
$6.56 | $12.50 | 113.41% | 0 | $280.15M |
| MSB | Mesoblast | Buy |
9
|
$0.99 | $0.69 | 11.11% | 0 | $299.37M |
| CGEN | Compugen | Buy |
7
|
$1.93 | $4.00 | 159.07% | 4 | $170.11M |
| XTNT | Xtant Medical Holdings | Buy |
0
|
$0.89 | $1.93 | 116.85% | 1 | $135.31M |
| PLUR | Pluri | - |
9
|
$5.60 | $4.00 | -100.00% | 0 | $27.35M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| BRTX | BioRestorative Therapies | Outperform |
0
|
$1.42 | $15.00 | 639.44% | 0 | $9.27M |
| RENE | ReNeuron Group |
7
|
£0.03 | £0.55 | 1733.33% | 1 | £1.93M | |
| ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
| ISCO | International Stem Cell | - |
4
|
$0.10 | $37.50 | -100.00% | 0 | $0.57M |
| PRED | Predictive Technology Group | - |
0
|
$0.00 | $7.00 | 0.00% | 0 | $0.03M |
| CRYO | American CryoStem | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| 542765 | Transpact Enterprises | - |
0
|
361.00 | 0.00 | -100.00% | 0 | 139.61M |